- 全部删除
- 您的购物车当前为空
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) 是一种可治疗中枢神经疾病和神经认知障碍的N-乙酰-L-半胱氨酸的前药,可用于治疗谷氨酸能功能障碍和氧化应激起关键作用的精神疾病。
为众多的药物研发团队赋能,
让新药发现更简单!
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) 是一种可治疗中枢神经疾病和神经认知障碍的N-乙酰-L-半胱氨酸的前药,可用于治疗谷氨酸能功能障碍和氧化应激起关键作用的精神疾病。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
1 mg | ¥ 109 | In stock | |
5 mg | ¥ 219 | In stock | |
10 mg | ¥ 313 | In stock | |
25 mg | ¥ 495 | In stock | |
50 mg | ¥ 793 | In stock | |
100 mg | ¥ 1,360 | In stock | |
200 mg | ¥ 1,980 | In stock |
产品描述 | SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role. |
别名 | (S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid |
分子量 | 281.33 |
分子式 | C13H15NO4S |
CAS No. | 1695562-36-7 |
Smiles | C(SC[C@H](NC(C)=O)C(O)=O)(=O)C1=CC=C(C)C=C1 |
存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
溶解度信息 | DMSO: 55 mg/mL (195.5 mM), Sonication is recommended. ![]() | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容